Jens Kuhn
Concepts (845)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viruses | 50 | 2026 | 166 | 15.430 |
Why?
| | Genome, Viral | 82 | 2026 | 214 | 14.160 |
Why?
| | RNA Viruses | 33 | 2025 | 73 | 13.050 |
Why?
| | Ebolavirus | 55 | 2026 | 91 | 10.410 |
Why?
| | Hemorrhagic Fever, Ebola | 44 | 2026 | 82 | 8.140 |
Why?
| | Phylogeny | 87 | 2025 | 917 | 8.050 |
Why?
| | Filoviridae | 22 | 2023 | 27 | 6.780 |
Why?
| | Terminology as Topic | 32 | 2026 | 259 | 6.170 |
Why?
| | Mononegavirales | 10 | 2022 | 10 | 5.060 |
Why?
| | Deep Brain Stimulation | 26 | 2026 | 220 | 4.830 |
Why?
| | Classification | 22 | 2026 | 44 | 4.490 |
Why?
| | Virus Replication | 42 | 2026 | 521 | 4.010 |
Why?
| | Arterivirus | 15 | 2024 | 18 | 3.640 |
Why?
| | Tourette Syndrome | 11 | 2025 | 27 | 3.410 |
Why?
| | RNA, Viral | 32 | 2024 | 693 | 3.340 |
Why?
| | Marburgvirus | 11 | 2024 | 21 | 2.960 |
Why?
| | Virion | 22 | 2025 | 108 | 2.790 |
Why?
| | Arenaviridae | 10 | 2024 | 12 | 2.760 |
Why?
| | Antiviral Agents | 17 | 2024 | 769 | 2.560 |
Why?
| | Arthropods | 4 | 2024 | 12 | 2.510 |
Why?
| | Viral Proteins | 21 | 2025 | 350 | 2.380 |
Why?
| | Animals | 167 | 2026 | 38101 | 2.340 |
Why?
| | Open Reading Frames | 10 | 2024 | 130 | 2.280 |
Why?
| | Hemorrhagic Fevers, Viral | 9 | 2022 | 16 | 2.220 |
Why?
| | Obsessive-Compulsive Disorder | 9 | 2026 | 61 | 2.210 |
Why?
| | Virus Internalization | 18 | 2022 | 65 | 2.120 |
Why?
| | Arterivirus Infections | 9 | 2019 | 10 | 2.100 |
Why?
| | Virology | 12 | 2025 | 36 | 2.060 |
Why?
| | Nucleoproteins | 10 | 2024 | 38 | 2.030 |
Why?
| | Host-Pathogen Interactions | 17 | 2026 | 361 | 1.990 |
Why?
| | Flaviviridae | 4 | 2025 | 10 | 1.950 |
Why?
| | Ebola Vaccines | 9 | 2026 | 13 | 1.910 |
Why?
| | Arenaviridae Infections | 9 | 2024 | 17 | 1.890 |
Why?
| | Filoviridae Infections | 5 | 2019 | 8 | 1.790 |
Why?
| | Rhabdoviridae | 4 | 2024 | 4 | 1.750 |
Why?
| | Viroids | 3 | 2024 | 5 | 1.700 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 8 | 2025 | 13 | 1.670 |
Why?
| | Receptors, Virus | 11 | 2015 | 95 | 1.660 |
Why?
| | Antibodies, Viral | 18 | 2026 | 674 | 1.630 |
Why?
| | Bunyaviridae | 4 | 2024 | 4 | 1.580 |
Why?
| | Hemorrhagic Fever, Crimean | 7 | 2025 | 11 | 1.570 |
Why?
| | DNA Viruses | 9 | 2025 | 23 | 1.570 |
Why?
| | Viral Vaccines | 9 | 2020 | 107 | 1.530 |
Why?
| | Monkey Diseases | 5 | 2020 | 25 | 1.490 |
Why?
| | Containment of Biohazards | 9 | 2026 | 23 | 1.320 |
Why?
| | Wasps | 6 | 2024 | 23 | 1.310 |
Why?
| | Humans | 201 | 2026 | 145783 | 1.310 |
Why?
| | Evolution, Molecular | 13 | 2025 | 494 | 1.300 |
Why?
| | Connectome | 4 | 2026 | 96 | 1.230 |
Why?
| | Disease Outbreaks | 20 | 2021 | 419 | 1.180 |
Why?
| | Chiroptera | 7 | 2021 | 59 | 1.150 |
Why?
| | Communicable Diseases, Emerging | 5 | 2025 | 39 | 1.150 |
Why?
| | Green Fluorescent Proteins | 3 | 2023 | 407 | 1.140 |
Why?
| | Nipah Virus | 3 | 2025 | 3 | 1.100 |
Why?
| | Lassa virus | 7 | 2023 | 9 | 1.090 |
Why?
| | Genetic Variation | 13 | 2020 | 977 | 1.090 |
Why?
| | Henipavirus Infections | 2 | 2025 | 2 | 1.080 |
Why?
| | Vero Cells | 18 | 2023 | 83 | 1.070 |
Why?
| | Viral Envelope Proteins | 12 | 2025 | 98 | 1.020 |
Why?
| | Brain | 15 | 2026 | 2969 | 1.000 |
Why?
| | Basal Nucleus of Meynert | 3 | 2017 | 4 | 1.000 |
Why?
| | Organoids | 2 | 2026 | 144 | 1.000 |
Why?
| | Delay Discounting | 3 | 2023 | 29 | 1.000 |
Why?
| | Drug Evaluation, Preclinical | 5 | 2020 | 196 | 0.970 |
Why?
| | Macaca mulatta | 12 | 2025 | 186 | 0.970 |
Why?
| | RNA Virus Infections | 5 | 2018 | 19 | 0.970 |
Why?
| | Monkeypox virus | 4 | 2025 | 23 | 0.950 |
Why?
| | Animal Use Alternatives | 1 | 2025 | 1 | 0.930 |
Why?
| | Biomedical Research | 6 | 2026 | 719 | 0.890 |
Why?
| | Coronavirus Infections | 8 | 2020 | 384 | 0.880 |
Why?
| | Pyrimidine Nucleosides | 2 | 2022 | 3 | 0.880 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2025 | 62 | 0.870 |
Why?
| | Glycoproteins | 13 | 2025 | 354 | 0.870 |
Why?
| | Nairovirus | 3 | 2024 | 3 | 0.860 |
Why?
| | Primates | 12 | 2023 | 133 | 0.840 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2025 | 78 | 0.840 |
Why?
| | Genomics | 13 | 2024 | 830 | 0.840 |
Why?
| | Archaeal Viruses | 4 | 2025 | 12 | 0.830 |
Why?
| | Helper Viruses | 1 | 2024 | 3 | 0.820 |
Why?
| | DNA, Complementary | 4 | 2021 | 273 | 0.810 |
Why?
| | Recombination, Genetic | 2 | 2024 | 205 | 0.810 |
Why?
| | Viral Core Proteins | 2 | 2020 | 21 | 0.800 |
Why?
| | Primate Diseases | 4 | 2018 | 8 | 0.800 |
Why?
| | Antibodies, Monoclonal | 7 | 2025 | 1505 | 0.790 |
Why?
| | Flavivirus | 1 | 2023 | 19 | 0.780 |
Why?
| | Antigens, CD | 7 | 2023 | 558 | 0.780 |
Why?
| | Cell Line | 21 | 2025 | 2823 | 0.780 |
Why?
| | Polydnaviridae | 1 | 2023 | 1 | 0.770 |
Why?
| | Rhabdoviridae Infections | 2 | 2020 | 2 | 0.760 |
Why?
| | Mammals | 6 | 2024 | 286 | 0.760 |
Why?
| | Arteriviridae | 4 | 2018 | 4 | 0.750 |
Why?
| | Thalamus | 5 | 2025 | 129 | 0.740 |
Why?
| | Databases, Nucleic Acid | 3 | 2023 | 38 | 0.740 |
Why?
| | Disease Reservoirs | 4 | 2017 | 25 | 0.730 |
Why?
| | Nucleus Accumbens | 10 | 2026 | 135 | 0.730 |
Why?
| | Arenaviruses, New World | 6 | 2013 | 9 | 0.730 |
Why?
| | Antibodies, Neutralizing | 9 | 2025 | 340 | 0.710 |
Why?
| | Frontal Lobe | 3 | 2025 | 160 | 0.690 |
Why?
| | Alzheimer Disease | 3 | 2017 | 630 | 0.680 |
Why?
| | Clinical Deterioration | 1 | 2021 | 10 | 0.670 |
Why?
| | Virus Diseases | 3 | 2020 | 216 | 0.670 |
Why?
| | Macaca | 6 | 2025 | 66 | 0.670 |
Why?
| | Pan troglodytes | 2 | 2021 | 62 | 0.660 |
Why?
| | Lassa Fever | 4 | 2023 | 6 | 0.660 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 11 | 0.660 |
Why?
| | Post-Exposure Prophylaxis | 2 | 2020 | 13 | 0.660 |
Why?
| | Parkinson Disease | 4 | 2022 | 601 | 0.660 |
Why?
| | Marburg Virus Disease | 4 | 2023 | 11 | 0.650 |
Why?
| | Picornaviridae | 1 | 2020 | 18 | 0.650 |
Why?
| | Impulsive Behavior | 2 | 2022 | 145 | 0.650 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 3 | 2023 | 66 | 0.640 |
Why?
| | Neutralization Tests | 3 | 2019 | 76 | 0.630 |
Why?
| | Symbiosis | 2 | 2024 | 72 | 0.630 |
Why?
| | Biological Evolution | 7 | 2024 | 468 | 0.630 |
Why?
| | Picornaviridae Infections | 1 | 2020 | 53 | 0.630 |
Why?
| | Biodiversity | 2 | 2022 | 311 | 0.620 |
Why?
| | International Cooperation | 3 | 2021 | 197 | 0.620 |
Why?
| | Receptors, Transferrin | 4 | 2013 | 28 | 0.620 |
Why?
| | World Health Organization | 2 | 2021 | 104 | 0.620 |
Why?
| | Bornaviridae | 2 | 2021 | 2 | 0.610 |
Why?
| | Metagenomics | 8 | 2024 | 150 | 0.600 |
Why?
| | Membrane Glycoproteins | 7 | 2015 | 499 | 0.590 |
Why?
| | Staining and Labeling | 2 | 2020 | 153 | 0.580 |
Why?
| | Luminescent Agents | 1 | 2018 | 7 | 0.570 |
Why?
| | Antipsychotic Agents | 1 | 2021 | 211 | 0.570 |
Why?
| | Receptors, Cell Surface | 4 | 2023 | 372 | 0.570 |
Why?
| | Internal Capsule | 6 | 2026 | 9 | 0.570 |
Why?
| | Sequence Analysis, DNA | 13 | 2017 | 778 | 0.560 |
Why?
| | Corpus Striatum | 1 | 2020 | 179 | 0.560 |
Why?
| | Genes, Reporter | 2 | 2018 | 277 | 0.550 |
Why?
| | Reverse Transcription | 1 | 2018 | 20 | 0.550 |
Why?
| | Macaca fascicularis | 3 | 2021 | 70 | 0.540 |
Why?
| | Archaea | 3 | 2025 | 61 | 0.540 |
Why?
| | Hantavirus Pulmonary Syndrome | 3 | 2023 | 5 | 0.540 |
Why?
| | Influenza A virus | 4 | 2025 | 119 | 0.530 |
Why?
| | Host Specificity | 7 | 2025 | 33 | 0.530 |
Why?
| | Amino Acid Sequence | 16 | 2020 | 2131 | 0.530 |
Why?
| | Evoked Potentials | 2 | 2018 | 131 | 0.530 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4568 | 0.520 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2020 | 534 | 0.510 |
Why?
| | Reaction Time | 2 | 2018 | 434 | 0.500 |
Why?
| | Bird Diseases | 2 | 2016 | 16 | 0.500 |
Why?
| | Ticks | 6 | 2025 | 30 | 0.500 |
Why?
| | Societies, Scientific | 2 | 2017 | 50 | 0.490 |
Why?
| | Endocytosis | 2 | 2014 | 168 | 0.490 |
Why?
| | Male | 56 | 2026 | 73010 | 0.480 |
Why?
| | Reverse Genetics | 4 | 2021 | 7 | 0.480 |
Why?
| | Neglected Diseases | 1 | 2016 | 5 | 0.480 |
Why?
| | Borna Disease | 2 | 2021 | 2 | 0.480 |
Why?
| | Colobus | 1 | 2016 | 3 | 0.480 |
Why?
| | Retroviridae | 4 | 2025 | 100 | 0.470 |
Why?
| | Cognitive Dysfunction | 1 | 2022 | 468 | 0.470 |
Why?
| | Dogs | 2 | 2015 | 478 | 0.470 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2016 | 15 | 0.460 |
Why?
| | HEK293 Cells | 11 | 2025 | 741 | 0.460 |
Why?
| | Subthalamic Nucleus | 4 | 2026 | 84 | 0.460 |
Why?
| | Hospitals, Psychiatric | 1 | 2015 | 29 | 0.460 |
Why?
| | Laboratories | 4 | 2016 | 110 | 0.460 |
Why?
| | Animal Assisted Therapy | 1 | 2015 | 13 | 0.450 |
Why?
| | Africa | 8 | 2021 | 119 | 0.450 |
Why?
| | Psychomotor Performance | 1 | 2018 | 324 | 0.450 |
Why?
| | Hospitals, University | 1 | 2015 | 176 | 0.440 |
Why?
| | Communicable Diseases | 2 | 2014 | 166 | 0.440 |
Why?
| | Female | 53 | 2026 | 79045 | 0.430 |
Why?
| | Insecta | 3 | 2024 | 71 | 0.430 |
Why?
| | Reflex, Startle | 2 | 2020 | 75 | 0.430 |
Why?
| | Nematoda | 2 | 2017 | 12 | 0.420 |
Why?
| | Tic Disorders | 1 | 2014 | 10 | 0.420 |
Why?
| | Depressive Disorder | 2 | 2015 | 374 | 0.420 |
Why?
| | Asymptomatic Infections | 4 | 2018 | 37 | 0.410 |
Why?
| | Plant Viruses | 3 | 2025 | 12 | 0.410 |
Why?
| | Reassortant Viruses | 1 | 2013 | 8 | 0.400 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2883 | 0.400 |
Why?
| | Aerosols | 5 | 2026 | 146 | 0.400 |
Why?
| | Virus Release | 5 | 2020 | 8 | 0.400 |
Why?
| | Communicable Disease Control | 1 | 2014 | 86 | 0.400 |
Why?
| | Cluster Analysis | 9 | 2019 | 501 | 0.390 |
Why?
| | Viral Load | 6 | 2020 | 526 | 0.390 |
Why?
| | Cricetinae | 6 | 2026 | 305 | 0.390 |
Why?
| | Mesocricetus | 5 | 2026 | 52 | 0.390 |
Why?
| | Positron Emission Tomography Computed Tomography | 2 | 2026 | 118 | 0.380 |
Why?
| | Animals, Laboratory | 1 | 2013 | 22 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 8 | 2025 | 3916 | 0.370 |
Why?
| | Neural Pathways | 4 | 2026 | 317 | 0.370 |
Why?
| | Infectious bronchitis virus | 3 | 2017 | 3 | 0.360 |
Why?
| | Treatment Outcome | 13 | 2023 | 11794 | 0.360 |
Why?
| | Zoonoses | 4 | 2022 | 39 | 0.360 |
Why?
| | Viruses, Unclassified | 2 | 2022 | 4 | 0.360 |
Why?
| | Suicide, Attempted | 2 | 2026 | 426 | 0.350 |
Why?
| | Bioterrorism | 1 | 2011 | 31 | 0.350 |
Why?
| | Capsid Proteins | 4 | 2025 | 94 | 0.340 |
Why?
| | Safety | 4 | 2016 | 358 | 0.340 |
Why?
| | Peptidyl-Dipeptidase A | 4 | 2007 | 56 | 0.340 |
Why?
| | Autistic Disorder | 1 | 2014 | 219 | 0.330 |
Why?
| | Occupational Health | 1 | 2014 | 213 | 0.330 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 41 | 0.330 |
Why?
| | Specimen Handling | 3 | 2025 | 183 | 0.330 |
Why?
| | Immunoglobulin G | 4 | 2026 | 892 | 0.330 |
Why?
| | Sequence Alignment | 7 | 2020 | 362 | 0.320 |
Why?
| | Viral Tropism | 3 | 2026 | 36 | 0.320 |
Why?
| | Bacteriophages | 3 | 2023 | 110 | 0.320 |
Why?
| | Animals, Wild | 4 | 2020 | 62 | 0.310 |
Why?
| | Plasmids | 2 | 2021 | 373 | 0.310 |
Why?
| | Neuroimaging | 2 | 2025 | 300 | 0.310 |
Why?
| | Adult | 27 | 2026 | 40881 | 0.310 |
Why?
| | Guinea Pigs | 8 | 2026 | 159 | 0.310 |
Why?
| | Beta Rhythm | 2 | 2024 | 33 | 0.310 |
Why?
| | Suicidal Ideation | 2 | 2026 | 584 | 0.310 |
Why?
| | Nervous System Diseases | 2 | 2010 | 286 | 0.300 |
Why?
| | Sequence Homology | 4 | 2017 | 43 | 0.300 |
Why?
| | RNA | 5 | 2023 | 912 | 0.290 |
Why?
| | Animal Diseases | 2 | 2022 | 9 | 0.290 |
Why?
| | Genotype | 6 | 2022 | 1857 | 0.290 |
Why?
| | Virulence | 4 | 2024 | 278 | 0.290 |
Why?
| | Pandemics | 5 | 2021 | 1711 | 0.280 |
Why?
| | Young Adult | 12 | 2026 | 14254 | 0.280 |
Why?
| | Mental Disorders | 2 | 2026 | 1171 | 0.280 |
Why?
| | Neuropsychological Tests | 4 | 2021 | 1137 | 0.280 |
Why?
| | Mice | 18 | 2025 | 18355 | 0.280 |
Why?
| | Antidepressive Agents | 2 | 2021 | 242 | 0.270 |
Why?
| | Electroencephalography | 6 | 2025 | 563 | 0.270 |
Why?
| | Pick Disease of the Brain | 1 | 2007 | 4 | 0.270 |
Why?
| | Africa, Western | 4 | 2020 | 21 | 0.260 |
Why?
| | Middle Aged | 21 | 2026 | 36309 | 0.250 |
Why?
| | Bayes Theorem | 4 | 2023 | 421 | 0.250 |
Why?
| | Tics | 2 | 2024 | 5 | 0.250 |
Why?
| | Medial Forebrain Bundle | 1 | 2026 | 1 | 0.250 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 533 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 387 | 0.250 |
Why?
| | Positron-Emission Tomography | 3 | 2022 | 343 | 0.250 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 4 | 2014 | 25 | 0.240 |
Why?
| | Depressive Disorder, Treatment-Resistant | 2 | 2017 | 13 | 0.240 |
Why?
| | Security Measures | 1 | 2026 | 7 | 0.240 |
Why?
| | Virus Cultivation | 2 | 2018 | 31 | 0.240 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 178 | 0.240 |
Why?
| | Aotidae | 1 | 2026 | 10 | 0.240 |
Why?
| | DNA, Viral | 4 | 2025 | 356 | 0.240 |
Why?
| | Gyrus Cinguli | 2 | 2017 | 97 | 0.240 |
Why?
| | ADP-Ribosylation | 1 | 2025 | 1 | 0.240 |
Why?
| | Viremia | 2 | 2025 | 160 | 0.230 |
Why?
| | Rumination, Cognitive | 1 | 2026 | 11 | 0.230 |
Why?
| | Replicon | 1 | 2025 | 12 | 0.230 |
Why?
| | Species Specificity | 2 | 2017 | 546 | 0.230 |
Why?
| | Metacognition | 1 | 2026 | 17 | 0.230 |
Why?
| | Toxicity Tests | 2 | 2016 | 53 | 0.230 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2026 | 31 | 0.230 |
Why?
| | RNA Helicases | 1 | 2025 | 27 | 0.230 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2026 | 161 | 0.230 |
Why?
| | Receptors, CXCR4 | 1 | 2026 | 91 | 0.230 |
Why?
| | Nucleocapsid Proteins | 3 | 2020 | 28 | 0.220 |
Why?
| | Germany | 4 | 2020 | 138 | 0.220 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2025 | 53 | 0.220 |
Why?
| | Genes, Viral | 3 | 2020 | 88 | 0.220 |
Why?
| | Virus Inactivation | 1 | 2025 | 13 | 0.220 |
Why?
| | Nerve Net | 4 | 2025 | 286 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 391 | 0.220 |
Why?
| | Dengue Virus | 1 | 2025 | 61 | 0.220 |
Why?
| | Schizophrenia | 2 | 2019 | 464 | 0.220 |
Why?
| | Respiratory System | 1 | 2026 | 150 | 0.210 |
Why?
| | Clinical Laboratory Techniques | 3 | 2020 | 96 | 0.210 |
Why?
| | Immunity, Humoral | 1 | 2025 | 118 | 0.210 |
Why?
| | Vaccination | 6 | 2026 | 1428 | 0.210 |
Why?
| | Fungal Viruses | 1 | 2024 | 1 | 0.210 |
Why?
| | Liberia | 6 | 2025 | 15 | 0.210 |
Why?
| | Poxviridae | 1 | 2024 | 3 | 0.210 |
Why?
| | Orthopoxvirus | 1 | 2024 | 4 | 0.210 |
Why?
| | Tenuivirus | 1 | 2024 | 1 | 0.210 |
Why?
| | Immunization, Secondary | 1 | 2024 | 92 | 0.210 |
Why?
| | Drug Discovery | 3 | 2015 | 153 | 0.210 |
Why?
| | Hemiptera | 1 | 2024 | 5 | 0.210 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 166 | 0.210 |
Why?
| | Ficus | 1 | 2024 | 2 | 0.210 |
Why?
| | History, 20th Century | 5 | 2020 | 328 | 0.200 |
Why?
| | One Health | 2 | 2021 | 10 | 0.200 |
Why?
| | Rodentia | 2 | 2021 | 61 | 0.200 |
Why?
| | Oryza | 1 | 2024 | 32 | 0.200 |
Why?
| | Lactate dehydrogenase-elevating virus | 1 | 2023 | 1 | 0.200 |
Why?
| | Proof of Concept Study | 2 | 2021 | 89 | 0.200 |
Why?
| | Base Sequence | 6 | 2017 | 2171 | 0.200 |
Why?
| | Ectopic Gene Expression | 1 | 2023 | 5 | 0.200 |
Why?
| | Models, Molecular | 9 | 2024 | 1599 | 0.200 |
Why?
| | Crustacea | 1 | 2023 | 5 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2020 | 1723 | 0.200 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 124 | 0.200 |
Why?
| | Uganda | 3 | 2020 | 90 | 0.190 |
Why?
| | Quality of Life | 6 | 2023 | 3211 | 0.190 |
Why?
| | Fungi | 1 | 2024 | 121 | 0.190 |
Why?
| | Public Health Surveillance | 2 | 2021 | 83 | 0.190 |
Why?
| | Drug Design | 1 | 2024 | 175 | 0.190 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2020 | 93 | 0.190 |
Why?
| | Dementia | 1 | 2007 | 328 | 0.190 |
Why?
| | Disinfectants | 1 | 2023 | 45 | 0.190 |
Why?
| | Electrodes, Implanted | 2 | 2020 | 114 | 0.190 |
Why?
| | Adolescent | 10 | 2026 | 22577 | 0.190 |
Why?
| | Frameshifting, Ribosomal | 2 | 2019 | 9 | 0.190 |
Why?
| | Biological Products | 2 | 2020 | 257 | 0.190 |
Why?
| | Vaccines, Attenuated | 2 | 2020 | 129 | 0.180 |
Why?
| | Plankton | 1 | 2022 | 8 | 0.180 |
Why?
| | Cytopathogenic Effect, Viral | 2 | 2020 | 16 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2023 | 375 | 0.180 |
Why?
| | Democratic Republic of the Congo | 3 | 2019 | 33 | 0.180 |
Why?
| | Seawater | 1 | 2022 | 33 | 0.180 |
Why?
| | Virus Physiological Phenomena | 2 | 2020 | 9 | 0.180 |
Why?
| | Viral Plaque Assay | 2 | 2025 | 29 | 0.180 |
Why?
| | Antigens, Differentiation | 2 | 2013 | 76 | 0.180 |
Why?
| | Cowpox virus | 1 | 2021 | 2 | 0.170 |
Why?
| | Fish Diseases | 1 | 2021 | 17 | 0.170 |
Why?
| | Ribavirin | 2 | 2020 | 81 | 0.170 |
Why?
| | Hepacivirus | 1 | 2023 | 242 | 0.170 |
Why?
| | Borna disease virus | 1 | 2021 | 1 | 0.170 |
Why?
| | Smallpox | 1 | 2021 | 10 | 0.170 |
Why?
| | HIV-1 | 3 | 2026 | 908 | 0.170 |
Why?
| | Dicistroviridae | 1 | 2021 | 7 | 0.170 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2019 | 36 | 0.170 |
Why?
| | Proteome | 2 | 2018 | 513 | 0.170 |
Why?
| | Sarcina | 1 | 2021 | 1 | 0.170 |
Why?
| | Uveitis | 1 | 2022 | 150 | 0.170 |
Why?
| | Fluvoxamine | 1 | 2021 | 18 | 0.170 |
Why?
| | Papio | 2 | 2018 | 70 | 0.170 |
Why?
| | Ape Diseases | 1 | 2021 | 7 | 0.170 |
Why?
| | Rubella virus | 1 | 2020 | 7 | 0.160 |
Why?
| | Plant Diseases | 2 | 2024 | 44 | 0.160 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 638 | 0.160 |
Why?
| | Addiction Medicine | 1 | 2021 | 14 | 0.160 |
Why?
| | Phlebovirus | 1 | 2020 | 6 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 232 | 0.160 |
Why?
| | Immunotoxins | 1 | 2021 | 55 | 0.160 |
Why?
| | Laboratory Infection | 1 | 2020 | 1 | 0.160 |
Why?
| | DNA Replication | 2 | 2020 | 249 | 0.160 |
Why?
| | Reward | 2 | 2020 | 248 | 0.160 |
Why?
| | Mutation | 9 | 2025 | 4090 | 0.160 |
Why?
| | Bunyaviridae Infections | 1 | 2020 | 15 | 0.160 |
Why?
| | DNA, Circular | 1 | 2020 | 15 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 289 | 0.160 |
Why?
| | Carrier State | 2 | 2020 | 78 | 0.160 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1062 | 0.160 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 27 | 0.160 |
Why?
| | RNA Polymerase II | 1 | 2024 | 350 | 0.160 |
Why?
| | Myocarditis | 1 | 2021 | 102 | 0.160 |
Why?
| | Hominidae | 1 | 2021 | 87 | 0.160 |
Why?
| | Semen | 2 | 2021 | 24 | 0.160 |
Why?
| | Caudovirales | 1 | 2020 | 1 | 0.160 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2021 | 72 | 0.160 |
Why?
| | DNA, Intergenic | 1 | 2020 | 26 | 0.160 |
Why?
| | Eukaryota | 3 | 2025 | 56 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 3551 | 0.160 |
Why?
| | Emphysema | 1 | 2021 | 100 | 0.150 |
Why?
| | Child Abuse | 1 | 2026 | 553 | 0.150 |
Why?
| | Arenavirus | 2 | 2020 | 2 | 0.150 |
Why?
| | Liver Diseases | 1 | 2023 | 305 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 979 | 0.150 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 442 | 0.150 |
Why?
| | Porcine respiratory and reproductive syndrome virus | 1 | 2019 | 1 | 0.150 |
Why?
| | Gastritis | 1 | 2021 | 117 | 0.150 |
Why?
| | In Situ Hybridization | 2 | 2020 | 318 | 0.150 |
Why?
| | Respiration | 2 | 2018 | 207 | 0.150 |
Why?
| | Databases, Pharmaceutical | 1 | 2019 | 4 | 0.150 |
Why?
| | Influenza, Human | 1 | 2025 | 624 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 365 | 0.150 |
Why?
| | Molecular Structure | 1 | 2020 | 487 | 0.150 |
Why?
| | A549 Cells | 4 | 2020 | 75 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2028 | 0.150 |
Why?
| | Drug Repositioning | 1 | 2019 | 39 | 0.150 |
Why?
| | Internationality | 3 | 2017 | 156 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 5 | 2025 | 849 | 0.150 |
Why?
| | DNA, Single-Stranded | 1 | 2020 | 117 | 0.150 |
Why?
| | Neuronavigation | 1 | 2019 | 8 | 0.140 |
Why?
| | Guinea | 2 | 2018 | 3 | 0.140 |
Why?
| | Gene Rearrangement | 1 | 2020 | 156 | 0.140 |
Why?
| | Ixodidae | 1 | 2019 | 7 | 0.140 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5428 | 0.140 |
Why?
| | Phage Therapy | 1 | 2019 | 17 | 0.140 |
Why?
| | Fluorometry | 1 | 2018 | 19 | 0.140 |
Why?
| | Tiletamine | 1 | 2018 | 2 | 0.140 |
Why?
| | Zolazepam | 1 | 2018 | 2 | 0.140 |
Why?
| | Shrews | 1 | 2018 | 3 | 0.140 |
Why?
| | Hepadnaviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Caulimoviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Immobilization | 1 | 2018 | 54 | 0.140 |
Why?
| | Cell Survival | 1 | 2022 | 1104 | 0.140 |
Why?
| | Cerebral Cortex | 2 | 2024 | 474 | 0.140 |
Why?
| | Mononegavirales Infections | 1 | 2018 | 1 | 0.140 |
Why?
| | Time Factors | 5 | 2026 | 7134 | 0.140 |
Why?
| | Schizophrenic Psychology | 1 | 2018 | 99 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2020 | 138 | 0.140 |
Why?
| | Midazolam | 1 | 2018 | 73 | 0.140 |
Why?
| | Spumavirus | 1 | 2018 | 3 | 0.140 |
Why?
| | Models, Neurological | 1 | 2020 | 250 | 0.140 |
Why?
| | Cell Membrane | 2 | 2020 | 709 | 0.140 |
Why?
| | Severe Acute Respiratory Syndrome | 3 | 2007 | 19 | 0.130 |
Why?
| | Committee Membership | 3 | 2023 | 5 | 0.130 |
Why?
| | Genomic Instability | 1 | 2018 | 68 | 0.130 |
Why?
| | Double-Blind Method | 4 | 2026 | 2064 | 0.130 |
Why?
| | Boidae | 1 | 2018 | 31 | 0.130 |
Why?
| | Encephalomyocarditis virus | 1 | 2017 | 1 | 0.130 |
Why?
| | Papio hamadryas | 1 | 2017 | 3 | 0.130 |
Why?
| | Cardiovirus Infections | 1 | 2017 | 3 | 0.130 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2018 | 25 | 0.130 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 51 | 0.130 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 55 | 0.130 |
Why?
| | Motivational Interviewing | 1 | 2019 | 121 | 0.130 |
Why?
| | Retroviridae Infections | 1 | 2018 | 47 | 0.130 |
Why?
| | Testis | 1 | 2018 | 162 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 560 | 0.130 |
Why?
| | Amino Acids | 2 | 2020 | 519 | 0.130 |
Why?
| | MicroRNAs | 1 | 2024 | 686 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 2 | 2025 | 473 | 0.130 |
Why?
| | Biotechnology | 1 | 2018 | 45 | 0.130 |
Why?
| | Software Design | 1 | 2017 | 25 | 0.130 |
Why?
| | Gene Order | 1 | 2017 | 29 | 0.130 |
Why?
| | Maryland | 2 | 2014 | 67 | 0.130 |
Why?
| | Acoustic Stimulation | 2 | 2020 | 333 | 0.130 |
Why?
| | Outpatients | 1 | 2021 | 447 | 0.130 |
Why?
| | Poultry Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 295 | 0.130 |
Why?
| | Diptera | 1 | 2017 | 30 | 0.130 |
Why?
| | Spike Glycoprotein, Coronavirus | 5 | 2017 | 129 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 821 | 0.120 |
Why?
| | Birds | 2 | 2017 | 86 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2023 | 2770 | 0.120 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 1 | 2016 | 6 | 0.120 |
Why?
| | Flaviviridae Infections | 1 | 2016 | 2 | 0.120 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 426 | 0.120 |
Why?
| | Zika Virus | 1 | 2018 | 136 | 0.120 |
Why?
| | Protective Clothing | 1 | 2016 | 15 | 0.120 |
Why?
| | Lentivirus Infections | 1 | 2016 | 9 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 783 | 0.120 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.120 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2016 | 39 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2017 | 1043 | 0.120 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 318 | 0.120 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2016 | 25 | 0.120 |
Why?
| | Viral Nonstructural Proteins | 3 | 2025 | 63 | 0.120 |
Why?
| | Functional Laterality | 1 | 2017 | 240 | 0.120 |
Why?
| | Macrophages | 4 | 2024 | 1507 | 0.120 |
Why?
| | Alphavirus | 1 | 2016 | 22 | 0.120 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 28 | 0.120 |
Why?
| | Plants | 3 | 2025 | 167 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 171 | 0.120 |
Why?
| | Selection, Genetic | 2 | 2017 | 263 | 0.120 |
Why?
| | Virus Attachment | 1 | 2015 | 19 | 0.120 |
Why?
| | Immunoassay | 1 | 2016 | 109 | 0.120 |
Why?
| | Satellite Viruses | 1 | 2015 | 1 | 0.120 |
Why?
| | Hemorrhage | 1 | 2021 | 822 | 0.120 |
Why?
| | Orthobunyavirus | 1 | 2015 | 8 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 826 | 0.120 |
Why?
| | Protein Binding | 7 | 2018 | 2240 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 139 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 172 | 0.120 |
Why?
| | Alphavirus Infections | 1 | 2016 | 45 | 0.110 |
Why?
| | Cell Cycle | 1 | 2018 | 598 | 0.110 |
Why?
| | Learning | 1 | 2020 | 444 | 0.110 |
Why?
| | Italy | 2 | 2025 | 117 | 0.110 |
Why?
| | Immunization, Passive | 1 | 2015 | 90 | 0.110 |
Why?
| | Rabbits | 3 | 2020 | 653 | 0.110 |
Why?
| | Skin | 1 | 2020 | 754 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2020 | 578 | 0.110 |
Why?
| | Lung | 3 | 2026 | 4116 | 0.110 |
Why?
| | Carboxypeptidases | 2 | 2005 | 12 | 0.110 |
Why?
| | Immune Evasion | 1 | 2015 | 61 | 0.110 |
Why?
| | Epitopes | 3 | 2025 | 473 | 0.110 |
Why?
| | Cysteine Proteases | 1 | 2014 | 8 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 80 | 0.110 |
Why?
| | DNA | 1 | 2021 | 1437 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1973 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2018 | 429 | 0.110 |
Why?
| | Computational Biology | 4 | 2025 | 669 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2019 | 588 | 0.110 |
Why?
| | RNA Interference | 2 | 2016 | 475 | 0.110 |
Why?
| | Compulsive Behavior | 1 | 2014 | 6 | 0.100 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.100 |
Why?
| | Veterinary Medicine | 1 | 2014 | 11 | 0.100 |
Why?
| | Asia | 3 | 2023 | 70 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2014 | 48 | 0.100 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1103 | 0.100 |
Why?
| | Aged | 8 | 2021 | 26217 | 0.100 |
Why?
| | Retrospective Studies | 9 | 2026 | 17330 | 0.100 |
Why?
| | Animals, Zoo | 3 | 2020 | 15 | 0.100 |
Why?
| | Dopamine Agonists | 1 | 2014 | 41 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 605 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 62 | 0.100 |
Why?
| | Endosomes | 2 | 2014 | 140 | 0.100 |
Why?
| | Forecasting | 1 | 2015 | 390 | 0.100 |
Why?
| | Comorbidity | 2 | 2020 | 1662 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 57 | 0.100 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.100 |
Why?
| | Rift Valley fever virus | 1 | 2013 | 3 | 0.100 |
Why?
| | Hepatocytes | 1 | 2014 | 224 | 0.100 |
Why?
| | Molecular Epidemiology | 3 | 2020 | 74 | 0.100 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2025 | 1166 | 0.100 |
Why?
| | Nucleic Acid Conformation | 1 | 2016 | 724 | 0.100 |
Why?
| | Psychometrics | 1 | 2017 | 732 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2017 | 410 | 0.100 |
Why?
| | Inhalation Exposure | 1 | 2014 | 103 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 82 | 0.090 |
Why?
| | Empathy | 1 | 2015 | 181 | 0.090 |
Why?
| | Survivors | 3 | 2022 | 523 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 344 | 0.090 |
Why?
| | Perception | 1 | 2016 | 378 | 0.090 |
Why?
| | Neural Inhibition | 1 | 2014 | 178 | 0.090 |
Why?
| | United States | 6 | 2024 | 16126 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 383 | 0.090 |
Why?
| | Oceans and Seas | 2 | 2022 | 22 | 0.090 |
Why?
| | Self Concept | 1 | 2014 | 254 | 0.090 |
Why?
| | Virosomes | 1 | 2012 | 2 | 0.090 |
Why?
| | Emotions | 2 | 2015 | 577 | 0.090 |
Why?
| | Protein Kinases | 1 | 2014 | 312 | 0.090 |
Why?
| | Diagnostic Errors | 2 | 2017 | 178 | 0.090 |
Why?
| | Cross Reactions | 1 | 2012 | 130 | 0.090 |
Why?
| | Global Health | 2 | 2021 | 403 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 963 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 456 | 0.080 |
Why?
| | Liver | 2 | 2018 | 1899 | 0.080 |
Why?
| | Bipolar Disorder | 1 | 2014 | 291 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 666 | 0.080 |
Why?
| | Invertebrates | 2 | 2021 | 21 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 729 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3195 | 0.080 |
Why?
| | Particle Size | 2 | 2026 | 381 | 0.080 |
Why?
| | Models, Animal | 2 | 2023 | 392 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2026 | 835 | 0.080 |
Why?
| | Cattle | 2 | 2016 | 946 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2021 | 2181 | 0.070 |
Why?
| | Prevalence | 4 | 2019 | 2875 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 447 | 0.070 |
Why?
| | Europe | 2 | 2025 | 421 | 0.070 |
Why?
| | Algorithms | 1 | 2017 | 1851 | 0.070 |
Why?
| | Viral Fusion Proteins | 1 | 2009 | 21 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1028 | 0.070 |
Why?
| | Sierra Leone | 2 | 2021 | 3 | 0.070 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 855 | 0.070 |
Why?
| | Sensory Gating | 2 | 2020 | 44 | 0.070 |
Why?
| | Ceruloplasmin | 1 | 2008 | 10 | 0.070 |
Why?
| | History, 21st Century | 3 | 2017 | 222 | 0.070 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2008 | 6 | 0.070 |
Why?
| | Up-Regulation | 2 | 2024 | 848 | 0.070 |
Why?
| | Interferons | 2 | 2020 | 186 | 0.070 |
Why?
| | Communication | 3 | 2021 | 977 | 0.070 |
Why?
| | Child | 3 | 2026 | 22740 | 0.070 |
Why?
| | Virus Assembly | 2 | 2020 | 82 | 0.070 |
Why?
| | Binding Sites | 5 | 2011 | 1311 | 0.070 |
Why?
| | Prospective Studies | 2 | 2026 | 8078 | 0.070 |
Why?
| | Brain Mapping | 2 | 2025 | 542 | 0.070 |
Why?
| | Rehabilitation, Vocational | 1 | 2007 | 5 | 0.070 |
Why?
| | Bacteria | 2 | 2025 | 766 | 0.070 |
Why?
| | Ecosystem | 2 | 2022 | 478 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 56 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2019 | 219 | 0.070 |
Why?
| | Coronavirus 229E, Human | 1 | 2007 | 7 | 0.070 |
Why?
| | Recurrence | 2 | 2022 | 1139 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2007 | 107 | 0.060 |
Why?
| | Atrophy | 1 | 2007 | 199 | 0.060 |
Why?
| | Morocco | 2 | 2017 | 3 | 0.060 |
Why?
| | Russia | 3 | 2017 | 12 | 0.060 |
Why?
| | Science | 1 | 2007 | 55 | 0.060 |
Why?
| | Anxiety | 1 | 2014 | 1122 | 0.060 |
Why?
| | Cats | 1 | 2007 | 234 | 0.060 |
Why?
| | Memory Disorders | 1 | 2007 | 197 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2014 | 3634 | 0.060 |
Why?
| | Diffusion Tensor Imaging | 1 | 2026 | 78 | 0.060 |
Why?
| | Vaccines, Synthetic | 2 | 2020 | 137 | 0.060 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2025 | 5 | 0.060 |
Why?
| | Haplorhini | 2 | 2016 | 52 | 0.060 |
Why?
| | Immunocompetence | 1 | 2026 | 46 | 0.060 |
Why?
| | Hexosyltransferases | 1 | 2025 | 6 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2006 | 115 | 0.060 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2025 | 17 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2601 | 0.060 |
Why?
| | Pyrimidines | 2 | 2020 | 530 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2026 | 94 | 0.060 |
Why?
| | Alpha Rhythm | 1 | 2025 | 11 | 0.060 |
Why?
| | Policy Making | 1 | 2026 | 83 | 0.060 |
Why?
| | Vesiculovirus | 1 | 2025 | 17 | 0.060 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 35 | 0.060 |
Why?
| | CD4 Antigens | 1 | 2026 | 137 | 0.060 |
Why?
| | Research Personnel | 1 | 2007 | 185 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2017 | 156 | 0.060 |
Why?
| | Comprehension | 1 | 2007 | 187 | 0.060 |
Why?
| | Chickens | 2 | 2016 | 179 | 0.060 |
Why?
| | Ecological Momentary Assessment | 1 | 2026 | 49 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 171 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2019 | 89 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 119 | 0.060 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2026 | 156 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 999 | 0.050 |
Why?
| | Hospitalization | 1 | 2015 | 2461 | 0.050 |
Why?
| | Phylogeography | 2 | 2015 | 50 | 0.050 |
Why?
| | Coronaviridae | 1 | 2024 | 4 | 0.050 |
Why?
| | Leukemia Virus, Murine | 1 | 2004 | 17 | 0.050 |
Why?
| | Gray Matter | 1 | 2025 | 92 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1074 | 0.050 |
Why?
| | Chikungunya virus | 1 | 2025 | 81 | 0.050 |
Why?
| | Immunogenicity, Vaccine | 1 | 2024 | 37 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2016 | 571 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1271 | 0.050 |
Why?
| | Fibrillin-2 | 1 | 2024 | 2 | 0.050 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2024 | 48 | 0.050 |
Why?
| | Virus Integration | 1 | 2024 | 69 | 0.050 |
Why?
| | Astrocytes | 1 | 2026 | 228 | 0.050 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 93 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2018 | 274 | 0.050 |
Why?
| | Heart | 2 | 2018 | 626 | 0.050 |
Why?
| | Attention | 1 | 2007 | 463 | 0.050 |
Why?
| | Pollination | 1 | 2024 | 22 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 222 | 0.050 |
Why?
| | Microglia | 1 | 2026 | 273 | 0.050 |
Why?
| | Antibody Formation | 1 | 2024 | 288 | 0.050 |
Why?
| | Crystallography, X-Ray | 1 | 2025 | 486 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2865 | 0.050 |
Why?
| | Canada | 1 | 2024 | 432 | 0.050 |
Why?
| | Anhedonia | 1 | 2023 | 18 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 146 | 0.050 |
Why?
| | Anesthesia | 2 | 2016 | 257 | 0.050 |
Why?
| | Ecology | 1 | 2024 | 105 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 173 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2022 | 13 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 414 | 0.040 |
Why?
| | Livestock | 1 | 2022 | 9 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2016 | 1300 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3418 | 0.040 |
Why?
| | Switzerland | 1 | 2021 | 46 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2022 | 165 | 0.040 |
Why?
| | Fresh Water | 1 | 2021 | 53 | 0.040 |
Why?
| | Pupa | 1 | 2021 | 14 | 0.040 |
Why?
| | Inpatients | 1 | 2026 | 553 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1261 | 0.040 |
Why?
| | Protein Subunits | 1 | 2022 | 229 | 0.040 |
Why?
| | Argentina | 1 | 2020 | 30 | 0.040 |
Why?
| | Rats | 2 | 2007 | 5585 | 0.040 |
Why?
| | Marsupialia | 1 | 2020 | 8 | 0.040 |
Why?
| | Equidae | 1 | 2020 | 7 | 0.040 |
Why?
| | Chromogenic Compounds | 1 | 2020 | 4 | 0.040 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2020 | 20 | 0.040 |
Why?
| | Republic of Korea | 1 | 2020 | 43 | 0.040 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.040 |
Why?
| | Genome Size | 1 | 2020 | 9 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2020 | 12 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2020 | 26 | 0.040 |
Why?
| | Membrane Fusion | 1 | 2020 | 41 | 0.040 |
Why?
| | Writing | 1 | 2022 | 101 | 0.040 |
Why?
| | Biomarkers | 2 | 2023 | 4302 | 0.040 |
Why?
| | Ferrets | 1 | 2020 | 31 | 0.040 |
Why?
| | Yugoslavia | 1 | 2020 | 4 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1184 | 0.040 |
Why?
| | Cues | 1 | 2023 | 329 | 0.040 |
Why?
| | Rubella | 1 | 2020 | 23 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2020 | 37 | 0.040 |
Why?
| | Diatoms | 1 | 2020 | 13 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 35 | 0.040 |
Why?
| | Psychotropic Drugs | 1 | 2021 | 78 | 0.040 |
Why?
| | Apoptosis | 2 | 2019 | 2444 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2020 | 33 | 0.040 |
Why?
| | Pathology, Molecular | 1 | 2020 | 25 | 0.040 |
Why?
| | Blood Chemical Analysis | 1 | 2020 | 109 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 110 | 0.040 |
Why?
| | Formaldehyde | 1 | 2020 | 65 | 0.040 |
Why?
| | Transaminases | 1 | 2020 | 22 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1708 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 149 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 174 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2020 | 170 | 0.040 |
Why?
| | Junin virus | 1 | 2019 | 1 | 0.040 |
Why?
| | Codon | 1 | 2020 | 92 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2019 | 37 | 0.040 |
Why?
| | HeLa Cells | 2 | 2012 | 632 | 0.040 |
Why?
| | Reptiles | 1 | 2019 | 4 | 0.040 |
Why?
| | Electron Transport Complex III | 1 | 2019 | 18 | 0.040 |
Why?
| | Haplotypes | 1 | 2021 | 500 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 320 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2020 | 182 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 2019 | 6 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2020 | 174 | 0.040 |
Why?
| | Convalescence | 1 | 2019 | 19 | 0.040 |
Why?
| | Erythrocebus | 1 | 2019 | 1 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 351 | 0.040 |
Why?
| | Asia, Western | 1 | 2019 | 5 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2021 | 239 | 0.040 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 956 | 0.040 |
Why?
| | U937 Cells | 1 | 2018 | 28 | 0.040 |
Why?
| | Viral Matrix Proteins | 1 | 2018 | 28 | 0.040 |
Why?
| | Analgesics | 1 | 2021 | 231 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 610 | 0.040 |
Why?
| | Fishes | 1 | 2019 | 110 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1482 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2018 | 64 | 0.040 |
Why?
| | Sertoli Cells | 1 | 2018 | 28 | 0.030 |
Why?
| | Transfection | 2 | 2011 | 927 | 0.030 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 46 | 0.030 |
Why?
| | Metagenome | 1 | 2019 | 126 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1036 | 0.030 |
Why?
| | Purines | 1 | 2019 | 187 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 146 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2019 | 219 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 563 | 0.030 |
Why?
| | Endocrine Glands | 1 | 2018 | 14 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2968 | 0.030 |
Why?
| | Ethanol | 1 | 2023 | 631 | 0.030 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.030 |
Why?
| | Tight Junctions | 1 | 2018 | 82 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2017 | 11 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 241 | 0.030 |
Why?
| | Spodoptera | 1 | 2017 | 40 | 0.030 |
Why?
| | Genitalia | 1 | 2018 | 33 | 0.030 |
Why?
| | Transcription Factors | 1 | 2006 | 1736 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11868 | 0.030 |
Why?
| | Machine Learning | 1 | 2023 | 587 | 0.030 |
Why?
| | RNA Editing | 1 | 2017 | 26 | 0.030 |
Why?
| | Epididymis | 1 | 2017 | 14 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1454 | 0.030 |
Why?
| | Exosomes | 1 | 2018 | 104 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 238 | 0.030 |
Why?
| | Autopsy | 1 | 2017 | 94 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2018 | 4151 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 121 | 0.030 |
Why?
| | Poultry | 1 | 2017 | 9 | 0.030 |
Why?
| | Sex Ratio | 1 | 2017 | 17 | 0.030 |
Why?
| | Databases, Factual | 1 | 2023 | 1491 | 0.030 |
Why?
| | Drug Combinations | 1 | 2018 | 396 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1049 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 180 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1898 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2017 | 203 | 0.030 |
Why?
| | Neurons | 1 | 2026 | 1652 | 0.030 |
Why?
| | Air Movements | 1 | 2016 | 9 | 0.030 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 3 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 361 | 0.030 |
Why?
| | HSC70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Laboratory Personnel | 1 | 2016 | 4 | 0.030 |
Why?
| | Climate | 1 | 2017 | 77 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2016 | 22 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 147 | 0.030 |
Why?
| | Vitreous Body | 1 | 2017 | 117 | 0.030 |
Why?
| | Animal Welfare | 1 | 2016 | 18 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2016 | 37 | 0.030 |
Why?
| | Nanopores | 1 | 2016 | 11 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 782 | 0.030 |
Why?
| | Geography | 1 | 2017 | 187 | 0.030 |
Why?
| | Diamines | 1 | 2016 | 5 | 0.030 |
Why?
| | Polysaccharides | 1 | 2016 | 86 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 61 | 0.030 |
Why?
| | trans-Golgi Network | 1 | 2016 | 15 | 0.030 |
Why?
| | Antibody-Dependent Enhancement | 1 | 2016 | 2 | 0.030 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 938 | 0.030 |
Why?
| | Epidemics | 1 | 2017 | 96 | 0.030 |
Why?
| | Tidal Volume | 1 | 2016 | 109 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2017 | 335 | 0.030 |
Why?
| | Benzothiazoles | 1 | 2016 | 39 | 0.030 |
Why?
| | Apathy | 1 | 2016 | 8 | 0.030 |
Why?
| | Travel | 1 | 2017 | 136 | 0.030 |
Why?
| | RNA, Satellite | 1 | 2015 | 1 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2016 | 61 | 0.030 |
Why?
| | Serogroup | 1 | 2015 | 45 | 0.030 |
Why?
| | Coitus | 1 | 2015 | 24 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2016 | 132 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 923 | 0.030 |
Why?
| | Cortical Synchronization | 1 | 2015 | 12 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 878 | 0.030 |
Why?
| | Unsafe Sex | 1 | 2015 | 61 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 411 | 0.030 |
Why?
| | Medication Adherence | 1 | 2019 | 540 | 0.030 |
Why?
| | Organic Chemicals | 1 | 2016 | 112 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 982 | 0.030 |
Why?
| | Motivation | 1 | 2019 | 602 | 0.030 |
Why?
| | Topography, Medical | 1 | 2014 | 10 | 0.030 |
Why?
| | Quinolines | 1 | 2016 | 190 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 849 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1271 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 856 | 0.030 |
Why?
| | Protein Transport | 1 | 2016 | 442 | 0.030 |
Why?
| | Psychological Tests | 1 | 2015 | 130 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1478 | 0.030 |
Why?
| | Drug Resistance, Viral | 1 | 2015 | 126 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1247 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 6033 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 174 | 0.030 |
Why?
| | Acari | 1 | 2013 | 2 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 264 | 0.030 |
Why?
| | Signal Transduction | 2 | 2019 | 5224 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2014 | 132 | 0.020 |
Why?
| | Actins | 1 | 2016 | 426 | 0.020 |
Why?
| | Hantaan virus | 1 | 2013 | 1 | 0.020 |
Why?
| | La Crosse virus | 1 | 2013 | 4 | 0.020 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2013 | 10 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 1001 | 0.020 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2013 | 11 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1812 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3170 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2014 | 148 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2014 | 107 | 0.020 |
Why?
| | Cercopithecus | 1 | 2012 | 3 | 0.020 |
Why?
| | Mood Disorders | 1 | 2014 | 144 | 0.020 |
Why?
| | rab GTP-Binding Proteins | 1 | 2013 | 76 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 335 | 0.020 |
Why?
| | Vaccines, Virosome | 1 | 2012 | 1 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1368 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2013 | 193 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1378 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 532 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 338 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 457 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Social Behavior | 1 | 2014 | 284 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10919 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4330 | 0.020 |
Why?
| | Middle East | 1 | 2011 | 18 | 0.020 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 25 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2000 | 0.020 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 111 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2069 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 337 | 0.020 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2010 | 11 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1372 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1139 | 0.020 |
Why?
| | GPI-Linked Proteins | 1 | 2010 | 81 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 177 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 615 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 544 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 334 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5992 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2008 | 6 | 0.020 |
Why?
| | Structural Homology, Protein | 1 | 2008 | 22 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 15 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 302 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2805 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3752 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2884 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 217 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1165 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 66 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 161 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 557 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2933 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2009 | 732 | 0.010 |
Why?
| | Viverridae | 1 | 2005 | 1 | 0.010 |
Why?
| | Antibodies | 1 | 2007 | 397 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1777 | 0.010 |
Why?
| | Iron | 1 | 2007 | 359 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2005 | 234 | 0.010 |
Why?
| | Incidence | 1 | 2011 | 2934 | 0.010 |
Why?
| | Asia, Central | 1 | 2003 | 1 | 0.010 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|